This AI Tool Could Spot Cancer Years Before Diagnosis— And The FDA Is Taking A Look - Pfizer (NYSE:PFE)

AI cancer detection tool seeks FDA approval as experts weigh benefits and risks of earlier diagnosis.

Raccontata dabenzinga.com